The role of surgery in gestational trophoblastic disease.

G. Bolis, C. Belloni, F. Vergadoro, N. Colombo, E. Buratti, C. Mangioni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Fifty-eight consecutive patients with malignant trophoblastic tumors of gestational origin were treated at the 1st Department of Obstetrics and Gynecology of the University of Milan between 1975 and 1981. Thirty-five (60.3%) of the patients were treated with combined surgery and chemotherapy. Of these, 44.8% had genital surgery, 12% extragenital surgery, and 5.1% had emergency laparotomies. Minor surgery was done to 17.1% of the patients. Five patients (20.8%) with tumors limited to the uterus and treated with chemotherapy only became drug-resistant, whereas 3 patients (9%) later developed lung metastases. All the patients are alive without any clinical signs of the disease. When there were metastatic tumors, the survival of the group first submitted to a "debulking" operation of the primary focus was 80%, and the survival of the group treated only with chemotherapy was 78.5%. Seven cases required extragenital surgery for the indications discussed in detail and because they had measurable HCG. Six of these had thoracotomies and one had a craniotomy. Five of the 6 patients who underwent thoracotomy (83.4%) had a complete remission. Chemotherapy remains the treatment of choice for trophoblastic tumors. Nevertheless, our data confirm that for some cases, mostly in the high risk group, complete eradication cannot be obtained with antitumor agents. Adjuvant surgery of carefully selected patients helps to save some of those who no longer respond to chemotherapy.

Original languageEnglish
Pages (from-to)553-557
Number of pages5
JournalTumori
Volume69
Issue number6
Publication statusPublished - Dec 31 1983

Fingerprint

Gestational Trophoblastic Disease
Drug Therapy
Trophoblastic Neoplasms
Thoracotomy
Minor Surgical Procedures
Hospital Obstetrics and Gynecology Department
Survival
Craniotomy
Gynecology
Antineoplastic Agents
Laparotomy
Uterus
Neoplasms
Emergencies
Neoplasm Metastasis
Lung

ASJC Scopus subject areas

  • Cancer Research

Cite this

Bolis, G., Belloni, C., Vergadoro, F., Colombo, N., Buratti, E., & Mangioni, C. (1983). The role of surgery in gestational trophoblastic disease. Tumori, 69(6), 553-557.

The role of surgery in gestational trophoblastic disease. / Bolis, G.; Belloni, C.; Vergadoro, F.; Colombo, N.; Buratti, E.; Mangioni, C.

In: Tumori, Vol. 69, No. 6, 31.12.1983, p. 553-557.

Research output: Contribution to journalArticle

Bolis, G, Belloni, C, Vergadoro, F, Colombo, N, Buratti, E & Mangioni, C 1983, 'The role of surgery in gestational trophoblastic disease.', Tumori, vol. 69, no. 6, pp. 553-557.
Bolis G, Belloni C, Vergadoro F, Colombo N, Buratti E, Mangioni C. The role of surgery in gestational trophoblastic disease. Tumori. 1983 Dec 31;69(6):553-557.
Bolis, G. ; Belloni, C. ; Vergadoro, F. ; Colombo, N. ; Buratti, E. ; Mangioni, C. / The role of surgery in gestational trophoblastic disease. In: Tumori. 1983 ; Vol. 69, No. 6. pp. 553-557.
@article{0d7920db6b554502b7e4e19b415e15c6,
title = "The role of surgery in gestational trophoblastic disease.",
abstract = "Fifty-eight consecutive patients with malignant trophoblastic tumors of gestational origin were treated at the 1st Department of Obstetrics and Gynecology of the University of Milan between 1975 and 1981. Thirty-five (60.3{\%}) of the patients were treated with combined surgery and chemotherapy. Of these, 44.8{\%} had genital surgery, 12{\%} extragenital surgery, and 5.1{\%} had emergency laparotomies. Minor surgery was done to 17.1{\%} of the patients. Five patients (20.8{\%}) with tumors limited to the uterus and treated with chemotherapy only became drug-resistant, whereas 3 patients (9{\%}) later developed lung metastases. All the patients are alive without any clinical signs of the disease. When there were metastatic tumors, the survival of the group first submitted to a {"}debulking{"} operation of the primary focus was 80{\%}, and the survival of the group treated only with chemotherapy was 78.5{\%}. Seven cases required extragenital surgery for the indications discussed in detail and because they had measurable HCG. Six of these had thoracotomies and one had a craniotomy. Five of the 6 patients who underwent thoracotomy (83.4{\%}) had a complete remission. Chemotherapy remains the treatment of choice for trophoblastic tumors. Nevertheless, our data confirm that for some cases, mostly in the high risk group, complete eradication cannot be obtained with antitumor agents. Adjuvant surgery of carefully selected patients helps to save some of those who no longer respond to chemotherapy.",
author = "G. Bolis and C. Belloni and F. Vergadoro and N. Colombo and E. Buratti and C. Mangioni",
year = "1983",
month = "12",
day = "31",
language = "English",
volume = "69",
pages = "553--557",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - The role of surgery in gestational trophoblastic disease.

AU - Bolis, G.

AU - Belloni, C.

AU - Vergadoro, F.

AU - Colombo, N.

AU - Buratti, E.

AU - Mangioni, C.

PY - 1983/12/31

Y1 - 1983/12/31

N2 - Fifty-eight consecutive patients with malignant trophoblastic tumors of gestational origin were treated at the 1st Department of Obstetrics and Gynecology of the University of Milan between 1975 and 1981. Thirty-five (60.3%) of the patients were treated with combined surgery and chemotherapy. Of these, 44.8% had genital surgery, 12% extragenital surgery, and 5.1% had emergency laparotomies. Minor surgery was done to 17.1% of the patients. Five patients (20.8%) with tumors limited to the uterus and treated with chemotherapy only became drug-resistant, whereas 3 patients (9%) later developed lung metastases. All the patients are alive without any clinical signs of the disease. When there were metastatic tumors, the survival of the group first submitted to a "debulking" operation of the primary focus was 80%, and the survival of the group treated only with chemotherapy was 78.5%. Seven cases required extragenital surgery for the indications discussed in detail and because they had measurable HCG. Six of these had thoracotomies and one had a craniotomy. Five of the 6 patients who underwent thoracotomy (83.4%) had a complete remission. Chemotherapy remains the treatment of choice for trophoblastic tumors. Nevertheless, our data confirm that for some cases, mostly in the high risk group, complete eradication cannot be obtained with antitumor agents. Adjuvant surgery of carefully selected patients helps to save some of those who no longer respond to chemotherapy.

AB - Fifty-eight consecutive patients with malignant trophoblastic tumors of gestational origin were treated at the 1st Department of Obstetrics and Gynecology of the University of Milan between 1975 and 1981. Thirty-five (60.3%) of the patients were treated with combined surgery and chemotherapy. Of these, 44.8% had genital surgery, 12% extragenital surgery, and 5.1% had emergency laparotomies. Minor surgery was done to 17.1% of the patients. Five patients (20.8%) with tumors limited to the uterus and treated with chemotherapy only became drug-resistant, whereas 3 patients (9%) later developed lung metastases. All the patients are alive without any clinical signs of the disease. When there were metastatic tumors, the survival of the group first submitted to a "debulking" operation of the primary focus was 80%, and the survival of the group treated only with chemotherapy was 78.5%. Seven cases required extragenital surgery for the indications discussed in detail and because they had measurable HCG. Six of these had thoracotomies and one had a craniotomy. Five of the 6 patients who underwent thoracotomy (83.4%) had a complete remission. Chemotherapy remains the treatment of choice for trophoblastic tumors. Nevertheless, our data confirm that for some cases, mostly in the high risk group, complete eradication cannot be obtained with antitumor agents. Adjuvant surgery of carefully selected patients helps to save some of those who no longer respond to chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0021116842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021116842&partnerID=8YFLogxK

M3 - Article

C2 - 6320512

AN - SCOPUS:0021116842

VL - 69

SP - 553

EP - 557

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -